Home Tools
Log in
Cart

Search Result

Search Results for " abemaciclib "

6

Compounds

Cat No. Product Name Synonyms Targets
T2381 Abemaciclib CDK4/6 dual inhibitor,LY2835219 CDK
Abemaciclib (LY2835219) is a dual inhibitor of CDK4/6 (IC50=2/10 nM) with selectivity and specificity. Abemaciclib has antitumor activity and is used to treat advanced or metastatic breast cancer.
T3111 Abemaciclib methanesulfonate abemaciclib mesylate,LY2835219,LY2835219 mesylate,LY2835219 (methanesulfonate) CDK
Abemaciclib methanesulfonate (LY2835219) is a specific and effective inhibitor of CDK4(IC50=2 nM) and CDK6(IC50=10 nM).
T10220 Abemaciclib metabolite M2 Abemaciclib Metabolites M2 CDK
Abemaciclib Metabolites M2 is a metabolite of abemaciclib, acts as a potent CDK4 and CDK6 inhibitor (IC50s: 1-3 nM) with anti-cancer activity.
T10738 Abemaciclib metabolite M20 CDK4/6-IN-4,LSN3106726 CDK
Abemaciclib metabolite M20 (CDK4/6-IN-4) is an active metabolite of Abemaciclib. Abemaciclib metabolite M20 is a selective CDK4/6 inhibitor and can be used for researches on the treatment of cancer.
T73909 Abemaciclib metabolite M18 LSN3106729 Ligands for Target Protein for PROTAC
Abemaciclib metabolite M18 (LSN3106729) is a potent cyclin-dependent kinase (CDK) inhibitor with antitumor properties. It has been incorporated alongside a cereblon (CRBN) ligand to develop a proteolysis-targeting chimer...
T36967 LSN3106729 hydrochloride
LSN3106729 hydrochloride, the metabolite of Abemaciclib , is a CDK inhibitor with antitumor activity. LSN3106729 hydrochloride and a CRBN ligand have been used to design PROTAC CDK4/6 degrader[1]. [1]. Edward S. Kim, et ...
TargetMol